U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Friday.

Shares of Zenas Biopharma Inc (NASDAQ:ZBIO) fell sharply in pre-market trading. Zenas BioPharma announced pricing of concurrent public offerings of 2.50% convertible senior notes due 2032 and common stock with aggregate gross proceeds of $300.0 million.

Zenas Biopharma shares dipped 9.5% to $20.05 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

• Daqo New Energy Corp (NYSE:DQ) fell 20% to $17.00 in pre-market trading. Daqo New Energy reported mixed quarterly results on Thursday.
• Armata Pharmaceuticals Inc (NYSE:ARMP) fell 9.1% to $8.50 in pre-market trading. Armata Pharmaceuticals posted a fourth-quarter loss of $3.43 per share after the closing bell on Wednesday.
• Upstream Bio Inc (NASDAQ:UPB) declined 8% to $9.01 in pre-market trading. Upstream Bio on Thursday announced a Phase 3 development strategy for its treatment, verekitug.
• Lithium Argentina AG (NYSE:LAR) fell 6.8% to $6.40 in pre-market trading.
• Enlight Renewable Energy Ltd (NASDAQ:ENLT) declined 6.6% to $67.17 in pre-market trading.
• CVR Partners LP (NYSE:UAN) declined 4.8% to $130.01 in pre-market trading.
• Inventiva ADR (NASDAQ:IVA) fell 4.2% to $5.84 in pre-market trading.
• Nokia Oyj (NYSE:NOK) declined 4.1% to $7.94 in pre-market trading.
• Adient PLC (NYSE:ADNT) fell 4% to $20.50 in pre-market trading.
• Nanobiotix SA – ADR (NASDAQ:NBTX) fell 3.7% to $30.15 in pre-market trading. NANOBIOTIX is scheduled to announce fourth quarter and full year 2025 operational and financial update on March 31.

Photo via Shutterstock